Fundraising Fox
Find your path to Rogier
Sign up to see every warm intro you have to Rogier
- Paths you didn't know you had: your email and LinkedIn already hold routes to Rogier. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Rogier Rooswinkel is a General Partner at Forbion's Naarden office, which he joined in 2013, where he evaluates and structures new investment opportunities across disease areas with a focus on oncology. Before Forbion, he was a post-doctoral researcher at the Netherlands Cancer Institute (NKI) in the division of immunology, and during his studies he worked as an independent website designer and founded an IT company. He earned a PhD Cum Laude from the University of Amsterdam in 2013 for work at the NKI, and holds a Master's degree in Oncology from VU University Amsterdam.
Invests in
Biotech
Investments
Board seats
AchillesAmphistaCatalymGraniteLoqus23PheonTessellate
Investor
Amphista TherapeuticsCatalYmEnterpriseGranite BioKaNDyLOQUS23 THERAPEUTICSPheon TherapeuticsReplimuneRigontecTessellate BIO
Sources: the firm's website · curated public sources.
Colleagues at Forbion
Frequently asked questions
- Who is Rogier Rooswinkel?
- Rogier Rooswinkel is a General Partner at Forbion's Naarden office, which he joined in 2013, where he evaluates and structures new investment opportunities across disease areas with a focus on oncology. Before Forbion, he was a post-doctoral researcher at the Netherlands Cancer Institute (NKI) in the division of immunology, and during his studies he worked as an independent website designer and founded an IT company. He earned a PhD Cum Laude from the University of Amsterdam in 2013 for work at the NKI, and holds a Master's degree in Oncology from VU University Amsterdam.
- Where does Rogier Rooswinkel work?
- Rogier Rooswinkel is General Partner at Forbion.
- What does Rogier Rooswinkel invest in?
- Rogier Rooswinkel invests in Biotech.
- What boards does Rogier Rooswinkel sit on?
- Rogier Rooswinkel holds tracked board seats at Achilles, Amphista, Catalym, Granite, Loqus23, Pheon, Tessellate.
- What companies has Rogier Rooswinkel invested in?
- Investments tracked here include Amphista Therapeutics, CatalYm, Enterprise, Granite Bio, KaNDy, LOQUS23 THERAPEUTICS, Pheon Therapeutics, Replimune, Rigontec, Tessellate BIO.
About this profile. Compiled from public sources — Forbion's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights